F-Box protein FBXO22 could mediate the polyubiquitination and degradation of CD147 by interacting with CD147, and CD147 polyubiquitination by FBXO22 reversed cisplatin resistance of tumor cells [5]. The gene discussed is FBXO22; the disease is neoplasm.